Anna Døssing, Birgitte Thorup Røge, Lone Galmstrup Madsen, Alex Lund Laursen, Jesper Bach Hansen, Jens Bukh, Nina Weis
Ugeskrift for laeger 2020 Feb 24In Denmark, about 50% of patients with chronic hepatitis C virus (HCV) infection are undiagnosed. Since 2014, therapy containing direct-acting antivirals (DAA) has proven efficient and is available to all patients, who have a chronic HCV infection and a Danish personal identification number. The World Health Organization has a goal of elimination of viral hepatitis in 2030. Elimination of HCV in Denmark should focus on reducing HCV transmission, incidence and prevalence, combined with treatment with DAA of all infected patients. Micro-elimination strategies may play a major role, but a national strategy is lacking.
Anna Døssing, Birgitte Thorup Røge, Lone Galmstrup Madsen, Alex Lund Laursen, Jesper Bach Hansen, Jens Bukh, Nina Weis. Elimination of hepatitis C virus in Denmark]. Ugeskrift for laeger. 2020 Feb 24;182(9)
PMID: 32138816
View Full Text